Literature DB >> 25573972

Future distribution of multiple myeloma in the United States by sex, age, and race/ethnicity.

Philip S Rosenberg1, Kimberly A Barker1, William F Anderson1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25573972      PMCID： PMC4287646          DOI： 10.1182/blood-2014-10-609461

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

Review 1.  Focus on multiple myeloma.

Authors:  Constantine S Mitsiades; Nicholas Mitsiades; Nikhil C Munshi; Kenneth C Anderson
Journal:  Cancer Cell       Date:  2004-11       Impact factor: 31.743

Review 2.  Predicting the future burden of cancer.

Authors:  Freddie Bray; Bjørn Møller
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

3.  Incidence of breast cancer in the United States: current and future trends.

Authors:  William F Anderson; Hormuzd A Katki; Philip S Rosenberg
Journal:  J Natl Cancer Inst       Date:  2011-07-13       Impact factor: 13.506

4.  Recent major improvement in long-term survival of younger patients with multiple myeloma.

Authors:  Hermann Brenner; Adam Gondos; Dianne Pulte
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

Review 5.  The epidemiology of multiple myeloma.

Authors:  D A Riedel; L M Pottern
Journal:  Hematol Oncol Clin North Am       Date:  1992-04       Impact factor: 3.722

6.  Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data.

Authors:  Dianne Pulte; Adam Gondos; Hermann Brenner
Journal:  Oncologist       Date:  2011-10-03

7.  Future of cancer incidence in the United States: burdens upon an aging, changing nation.

Authors:  Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz
Journal:  J Clin Oncol       Date:  2009-04-29       Impact factor: 44.544

8.  Improved survival in multiple myeloma and the impact of novel therapies.

Authors:  Shaji K Kumar; S Vincent Rajkumar; Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Francis K Buadi; Steven R Zeldenrust; David Dingli; Stephen J Russell; John A Lust; Philip R Greipp; Robert A Kyle; Morie A Gertz
Journal:  Blood       Date:  2007-11-01       Impact factor: 22.113

Review 9.  Multiple myeloma in the older adult: better prospects, more challenges.

Authors:  Tanya M Wildes; Ashley Rosko; Sascha A Tuchman
Journal:  J Clin Oncol       Date:  2014-08-20       Impact factor: 44.544
  9 in total
  17 in total

Review 1.  Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologist.

Authors:  Tanya M Wildes; Kenneth C Anderson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Management of Newly Diagnosed Elderly Multiple Myeloma Patients.

Authors:  Crystal Antoine-Pepeljugoski; Marc Justin Braunstein
Journal:  Curr Oncol Rep       Date:  2019-05-24       Impact factor: 5.075

3.  Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma.

Authors:  Hira Mian; Mark Fiala; Tanya M Wildes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-10-09

4.  How are patient-reported outcomes and symptoms being measured in adults with relapsed/refractory multiple myeloma? A systematic review.

Authors:  Matthew R LeBlanc; Rachel Hirschey; Ashley Leak Bryant; Thomas W LeBlanc; Sophia K Smith
Journal:  Qual Life Res       Date:  2019-12-17       Impact factor: 4.147

Review 5.  Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival.

Authors:  Ingemar Turesson; Magnus Bjorkholm; Cecilie Hveding Blimark; Sigurdur Kristinsson; Ramon Velez; Ola Landgren
Journal:  Eur J Haematol       Date:  2018-04-20       Impact factor: 2.997

6.  Geriatric Assessment in Older Adults with Multiple Myeloma.

Authors:  Tanya M Wildes; Sascha A Tuchman; Heidi D Klepin; Joseph Mikhael; Kathryn Trinkaus; Keith Stockerl-Goldstein; Ravi Vij; Graham Colditz
Journal:  J Am Geriatr Soc       Date:  2018-12-13       Impact factor: 5.562

7.  Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma.

Authors:  Matthew Ho; Maria Moscvin; Soon Khai Low; Benjamin Evans; Sara Close; Robert Schlossman; Jacob Laubach; Claudia Paba Prada; Brett Glotzbecker; Paul G Richardson; Giada Bianchi
Journal:  Leuk Lymphoma       Date:  2022-06-14

Review 8.  Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.

Authors:  Tanya M Wildes; Erica Campagnaro
Journal:  J Geriatr Oncol       Date:  2016-04-23       Impact factor: 3.599

9.  Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide Era.

Authors:  Andrew Johnsrud; Abdullah Ladha; Lori Muffly; Parveen Shiraz; Gary Goldstein; Victoria Osgood; Judith A Shizuru; Laura Johnston; Sally Arai; Wen-Kai Weng; Robert Lowsky; Andrew R Rezvani; Everett H Meyer; Matthew J Frank; Robert S Negrin; David B Miklos; Surbhi Sidana
Journal:  Transplant Cell Ther       Date:  2021-04-26

10.  Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myeloma.

Authors:  Nitya Nathwani; Jill Bell; Dasha Cherepanov; France Ginchereau Sowell; Rachel Shah; Kelly McCarrier; Parameswaran Hari
Journal:  Support Care Cancer       Date:  2022-04-01       Impact factor: 3.359
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.